On the assessment of similarity for dissolution profiles of two drug products

Journal of Biopharmaceutical Statistics

Volumn 12, Issue 3, 2002, Pages 311-321

  Chow, Shein Chung ^a   Shao, Jun ^b  

^a StatPlus Inc   (United States)

^b University of Wisconsin Madison   (United States)

Author keywords

Global similarity; Local similarity; Simultaneous confidence intervals; Time series

Indexed keywords

ARTICLE; DISSOLUTION; DRUG ANALYSIS; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ALGORITHMS; KINETICS; MODELS, STATISTICAL; PHARMACEUTICAL PREPARATIONS; SOLUBILITY;

EID: 0036429995     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-120014561     Document Type: Article

References (16)

1. Chow, S.C.; Ki, F.Y.C. Statistical comparison between dissolution profiles of drug products. J. Biopharm. Stat. 1997, 7, 241-258.
2. Tsong, Y.; Hammerstorm, T.; Lin, K.K.; Ong, T.E. The dissolution testing sampling acceptance rules. J. Biopharm. Stat. 1995, 5, 171-184.
3. Langenbucher, F. Linearization of dissolution rate curves by the weibull distribution. J. Pharm. Pharmacol. 1972, 24, 979-981.
4. Dawoodbhai, S.; Suryanarayan, E.; Woodruff, C.; Rhodes, C. Optimization of tablet formulation containing talc. Drug Dev. Ind. Pharm. 1991, 17, 1343-1371.
5. Pena Romero, A.; Caramella, C.; Ronchi, M.; Ferrari, F.; Chulia, D. Water uptake and force development in an optimized prolonged release formulation. Int. J. Pharm. 1991, 73, 239-248.
6. Kervinen, L.; Yliruusi, J. Modeling S-shaped dissolution curves. Int. J. Pharm. 1993, 92, 115-122.
7. Tsong, Y.; Hammerstrom, T.; Chen, J.J. Multiple dissolution specification and acceptance sampling rule based on profile modeling and principal component analysis. J. Biopharm. Stat. 1997, 7, 423-439.
8. Gill, J.L. Repeated measurement: Split-plot trend analysis versus analysis of first differences. Biometrics 1988, 44, 289-297.
9. Moore, J.W.; Flanner, H.H. Mathematical comparison of curves with an emphasis on dissolution profiles. Pharm. Technol. 1996, 20, 64-74.
10. SUPAC-IR, Guidance on Immediate Release Solid Oral Dosage Forms, Scale-up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing, and In Vivo Bioequivalence Documentation, The U.S. Food and Drug Administration: Rockville, Maryland, 1995.
11. 2 as a criterion for assessment of similarity between dissolution profiles. Drug Inf. J. 1997, 31, 1225-1271.
12. Shah, V.P.; Tsong, Y.; Sathe, P.; Liu, J.P. In vitro dissolution profile comparison: Statistics and analysis of the similarity factor f2. Pharm. Res. 1998, 15, 889-896.
13. Tsong, Y.; Hammerstorm, T.; Sathe, P.; Shah, V.P. Statistical assessment of mean differences between two dissolution data sets. Drug Inf. J. 1996, 30, 1105-1112.
14. Ma, M.C.; Lin, R.P.; Liu, J.P. Statistical evaluation of dissolution similarity. Stat. Sin. 1999, 9, 1011-1028.
15. Fuller, W.A. Introduction to Statistical Time Series, 2nd Ed.; Wiley: New York, 1996.
16. Shao, J. Mathematical Statistics; Springer: New York, 1999.